mortality/aging
• reduced mortality following EMCV infection
|
immune system
• elevated Ifnb1 expression in cultured macrophages in response to viral infection
|
• following EMCV, HSV-1, or VSV infection
|
• elevated after VSV or HSV-1 infection
|
• elevated levels of Ifnb1 in the heart and brain 48 and 72 hours following EMCV injection
• elevation is also seen after infection with VSV
|
• elevated Ifna4 levels following VSV or HSV-1 infection
|
• following EMCV, HSV-1, or VSV infection
|
• in macrophages following viral infection
|
• lower titers of herpes simplex virus 1 (HSV-1) in the brain
|
• following infection with vesicular stomatitis virus (VSV) viral titers are lower in liver spleen and lung
|
• following infection with encephalomyocarditis virus (EMCV) viral titers in heart and brain are lower, fewer signs of severe inflammation are seen in the heart and brain, and few signs of nerve cell degeneration and inflammatory cell infiltration in the brain
|
• reduced mortality following EMCV infection
|
homeostasis/metabolism
• following EMCV, HSV-1, or VSV infection
|
• elevated after VSV or HSV-1 infection
|
• elevated levels of Ifnb1 in the heart and brain 48 and 72 hours following EMCV injection
• elevation is also seen after infection with VSV
|
• elevated Ifna4 levels following VSV or HSV-1 infection
|
• following EMCV, HSV-1, or VSV infection
|
hematopoietic system
• elevated Ifnb1 expression in cultured macrophages in response to viral infection
|